Britannia Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	16	12	11	15	31	-
Market Cap Growth	42.86%	7.14%	-26.32%	-49.89%	-	-
Enterprise Value	18	23	21	25	38	-
Last Close Price	0.10	0.07	0.07	0.10	0.19	-
PE Ratio	1.97	1.65	-	3.03	-	-
PS Ratio	62.27	32.95	21.98	2.41	4.21	-
PB Ratio	3.21	1.93	1.70	1.39	5.61	-
P/TBV Ratio	3.21	1.93	-	-	-	-
P/FCF Ratio	-	-	5.43	7.89	11.34	-
P/OCF Ratio	-	-	5.43	7.68	10.99	-
EV/Sales Ratio	68.33	62.12	40.45	3.90	5.26	-
EV/EBITDA Ratio	-	-	-	22.64	21.88	-
EV/EBIT Ratio	-	-	-	25.15	23.75	-
EV/FCF Ratio	-	-	9.99	12.80	14.15	-
Debt / Equity Ratio	0.48	0.30	1.09	0.76	0.95	3.96
Debt / EBITDA Ratio	-	-	-	7.31	2.88	32.63
Debt / FCF Ratio	-	-	3.48	4.31	1.92	-
Asset Turnover	0.02	0.02	0.02	0.29	0.34	0.13
Quick Ratio	0.38	2.21	0.24	0.91	0.41	0.25
Current Ratio	1.00	2.72	0.26	0.92	0.42	0.25
Return on Equity (ROE)	-58.92%	-70.32%	-68.98%	70.57%	-343.40%	10.72%
Return on Assets (ROA)	-10.34%	-8.18%	-4.23%	2.78%	4.75%	1.67%
Return on Invested Capital (ROIC)	-69.61%	-34.23%	-10.50%	7.65%	15.08%	0.90%
Return on Capital Employed (ROCE)	-37.50%	-27.80%	-13.20%	5.20%	12.70%	2.60%
Earnings Yield	50.68%	60.75%	-41.98%	32.98%	-50.26%	-
FCF Yield	-	-21.53%	18.42%	12.67%	8.82%	-
Buyback Yield / Dilution	0.03%	-	-0.07%	-48.07%	-41.06%	-1138.06%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.